KOSÉ (4922) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
7 Aug, 2025Executive summary
Net sales for 1H 2025 rose 0.9% year-over-year to ¥160.5 billion, with overseas sales comprising 34.7% of the total, driven by strong growth in Japan but offset by declines in Greater China and Tarte's performance in North America and Europe.
Operating profit fell 17.7% year-over-year to ¥11.3 billion, mainly due to increased SG&A expenses, including goodwill amortization from PURI and higher logistics costs at Tarte.
Profit attributable to owners dropped 38.9% year-over-year to ¥7.0 billion, impacted by foreign exchange losses from yen appreciation and lower extraordinary gains.
Comprehensive income fell 86.7% year-over-year to ¥2,341 million.
Financial highlights
Gross profit increased slightly to ¥113.2 billion, but SG&A expenses rose by ¥2.9 billion, mainly from selling and administrative costs.
Ordinary profit declined 49.1% year-over-year to ¥9.6 billion, mainly due to foreign exchange losses.
Net income per share decreased from 203.47 yen to 124.36 yen year-over-year.
Capital expenditures for 1H 2025 were ¥13.4 billion, up from ¥5.6 billion in 1H 2024.
Total assets decreased to ¥368.3 billion from ¥386.8 billion at year-end 2024.
Outlook and guidance
No revision to the 2025 full-year outlook: net sales projected at ¥336.0 billion (+4.1% YoY), operating profit at ¥20.0 billion (+15.2% YoY), and profit attributable to owners at ¥13.8 billion (+83.7% YoY).
Strong sales in Japan expected to offset shortfalls in Tarte and Asia.
Dividend for 2025 maintained at ¥140 per share.
No revisions to the previously announced full-year forecast.
Latest events from KOSÉ
- FY2025 delivered higher sales and profit, with FY2026 targeting further growth but lower net income.4922
Q4 202512 Feb 2026 - Sales up slightly, but profit down on higher costs and FX losses; full-year outlook maintained.4922
Q3 202510 Nov 2025 - Double-digit profit growth led by Japan and North America, while China lags.4922
Q2 202413 Jun 2025 - Sales growth offset by China restructuring loss; profit outlook cut, dividend steady.4922
Q3 202413 Jun 2025 - Sales up, profits down; 2025 outlook positive despite cost and FX headwinds.4922
Q1 20256 Jun 2025 - 2024 profit fell on China reforms, but 2025 outlook is for strong recovery and sales growth.4922
Q4 20246 Jun 2025